Biosimilars: Interchangeable Products May Increase Patient Access

Switch to:

Biosimilars: Interchangeable Products May Increase Patient Access

06/21/2022

Depending on state pharmacy laws, you may substitute an interchangeable biosimilar product at the pharmacy, much like substituting a generic for a brand-name drug. This helps increase patient access to biologics and may reduce patient costs. Learn more about Interchangeable Biological Products from the FDA. Bookmark FDA’s Biosimilars web page and materials for health care providers and patients.

Additional FDA resources you may find helpful:

Provider Update